Endobiliary Ablation Combined with Immune Nutrition Improves Quality of Life: A Preliminary Clinical Study in Patients with Advanced Malignant Obstructive Jaundice

15 September 2022 : Clinical Research

Jie Yao^1ABE, Yalin Kong^2A*, Cheng Wang^2C, Yaping Wei^1BD, Hailian Li^1DE, Chengli Liu^23DEF

DOI: 10.12659/MSM.936863

Med Sci Monit 2022; 28:e936863

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 4 Secondary outcomes of the studied groups.

Variable	Study group (n=31)	Control group (n=28)	P value
	11.3±4.7	12.6±4.2	0.268
	7.7±3.1	7.5±2.8	0.562

CRP (mg/L)	15.2±6.2	38.6±11.4	0.027^*
IL-1 (pg/ml)	64.3±12.4	103.6±18.6	0.016^*
IL-6 (pg/ml)	132.4±43.7	288.6±33.6	<0.01^*
TNF-α (pg/mL)	1638±76.4	2168±87.8	0.036^*
	14 (45.2%)	12 (42.9%)	0.550
Infection	7 (22.6%)	6 (21.4%)	0.589
Biliary bleeding	5 (16.1%)	4 (14.3%)	0.577
Acute pancreatitis	1 (3.2%)	2 (7.1%)	0.607
Moderate pain	6 (19.4%)	4 (14.3%)	0.742
^*

Back to the Article